Home » Topics » Disease categories and therapies » Substance use and poisoning

Substance use and poisoning
RSS

Britannia and US WorldMeds sign licensing agreement for lofexidine

Nov. 21, 2003

Novel 5-HT and/or dopamine receptor ligands discovered by Sepracor team

Nov. 19, 2003

Antalarmin reduces volitional ethanol consumption in rats

Nov. 18, 2003

Neramexane shows promise for the treatment of alcohol dependence

Nov. 18, 2003

TA-CD advances into phase IIb for cocaine addiction

Oct. 28, 2003

TA-NIC enters second phase I trial

Oct. 10, 2003

Potential benefits reported for the anticonvulsant vigabatrin in cocaine addiction

Oct. 7, 2003

SSR-591813, a partial alpha4beta2 nAChR agonist, effective in animal models of nicotine dependence

Aug. 29, 2003

New phase II trial evaluates NicVAX in smokers

Aug. 7, 2003

JT patent covers new inhibitors of sodium-phosphate cotransporter and their use

Aug. 6, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 21, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 21, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...